• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma.

作者信息

Jacków Joanna, Rami Avina, Hayashi Ryota, Hansen Corey, Guo Zongyou, DeLorenzo Dominick, Pappalardo Alberto, Alvarez Cespedes David, Kim Arianna L, Perez-Lorenzo Rolando, Owens David M, Christiano Angela M

机构信息

Department of Dermatology, Columbia University, New York, New York, USA; St John's Institute of Dermatology, King's College London (Guy's campus), London, United Kingdom.

Department of Dermatology, Columbia University, New York, New York, USA.

出版信息

J Invest Dermatol. 2021 Apr;141(4):942-946. doi: 10.1016/j.jid.2020.08.022. Epub 2020 Oct 16.

DOI:10.1016/j.jid.2020.08.022
PMID:33069729
Abstract
摘要

相似文献

1
Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma.在隐性营养不良性大疱性表皮松解症-鳞状细胞癌小鼠模型中用鲁索替尼靶向Jak/信号转导子和转录激活子3通路
J Invest Dermatol. 2021 Apr;141(4):942-946. doi: 10.1016/j.jid.2020.08.022. Epub 2020 Oct 16.
2
Pembrolizumab for Treatment of a Patient With Multiple Cutaneous Squamous Cell Carcinomas and Recessive Dystrophic Epidermolysis Bullosa.帕博利珠单抗治疗多发性皮肤鳞状细胞癌合并隐性营养不良性大疱性表皮松解症患者
JAMA Dermatol. 2020 Jun 1;156(6):708-710. doi: 10.1001/jamadermatol.2020.0304.
3
Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.了解隐性营养不良型大疱性表皮松解症鳞状细胞癌的发病机制。
Dermatol Clin. 2010 Jan;28(1):171-8. doi: 10.1016/j.det.2009.10.023.
4
Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.与隐性营养不良性大疱性表皮松解症相关的鳞状细胞癌的基因图谱揭示了NOTCH和TP53突变以及MYC表达增加。
J Invest Dermatol. 2018 Jun;138(6):1423-1427. doi: 10.1016/j.jid.2017.12.026. Epub 2017 Dec 29.
5
Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC.VII 型胶原对皮肤 SCC 中 TGFβ 和血管生成的抑制作用。
J Natl Cancer Inst. 2015 Oct 16;108(1). doi: 10.1093/jnci/djv293. Print 2016 Jan.
6
Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis.隐性营养不良性大疱性表皮松解症相关鳞状细胞癌：一种发病机制复杂的神秘疾病。
J Invest Dermatol. 2007 Oct;127(10):2295-6. doi: 10.1038/sj.jid.5700939.
7
A recurrent nonsense mutation occurring as a de novo event in a patient with recessive dystrophic epidermolysis bullosa.在一名隐性营养不良型大疱性表皮松解症患者中作为新生事件出现的复发性无义突变。
Dermatology. 2011;223(3):219-21. doi: 10.1159/000330331. Epub 2011 Aug 18.
8
Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa.创伤愈合受损、纤维化和癌症：隐性营养不良性大疱性表皮松解症的范例。
Int J Mol Sci. 2021 May 12;22(10):5104. doi: 10.3390/ijms22105104.
9
Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.西米普利单抗治疗重度隐性营养不良性大疱性表皮松解症患者的鳞状细胞癌
J Dtsch Dermatol Ges. 2023 Mar;21(3):295-297. doi: 10.1111/ddg.14980. Epub 2023 Feb 28.
10
Cancer. An anchor for tumor cell invasion.癌症。肿瘤细胞侵袭的一个锚定因素。
Science. 2005 Mar 18;307(5716):1727-8. doi: 10.1126/science.1110346.

引用本文的文献

1
The COL7A1/PI3K/AKT axis regulates the progression of cholangiocarcinoma.COL7A1/PI3K/AKT轴调控胆管癌的进展。
Heliyon. 2024 Sep 7;10(18):e37361. doi: 10.1016/j.heliyon.2024.e37361. eCollection 2024 Sep 30.
2
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa.用于大疱性表皮松解症的可扩展和 cGMP 兼容的自体器官型细胞疗法。
Nat Commun. 2024 Jul 11;15(1):5834. doi: 10.1038/s41467-024-49400-z.
3
Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin.
胶原 VII 缺陷皮肤中炎症介导的成纤维细胞活化和免疫失调。
Front Immunol. 2023 Sep 20;14:1211505. doi: 10.3389/fimmu.2023.1211505. eCollection 2023.
4
Squamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature.遗传性大疱性表皮松解症患者的鳞状细胞癌：文献复习。
Cells. 2022 Apr 17;11(8):1365. doi: 10.3390/cells11081365.
5
Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.大疱性表皮松解症相关皮肤鳞癌：28 年回顾性研究。
Acta Derm Venereol. 2021 Aug 24;101(8):adv00523. doi: 10.2340/00015555-3875.
6
Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa.创伤愈合受损、纤维化和癌症：隐性营养不良性大疱性表皮松解症的范例。
Int J Mol Sci. 2021 May 12;22(10):5104. doi: 10.3390/ijms22105104.
7
Reprogramming and Differentiation of Cutaneous Squamous Cell Carcinoma Cells in Recessive Dystrophic Epidermolysis Bullosa.隐性营养不良型大疱性表皮松解症皮肤鳞状细胞癌细胞的重编程与分化。
Int J Mol Sci. 2020 Dec 29;22(1):245. doi: 10.3390/ijms22010245.